Share: Net Revenues: $97.4 million, a 20% increase Net Income: $17.3 million, a 15.9 million increase, Adjusted EBITDA: $26.2 million, a 44% increase, and Adjusted EBITDA margin of 27%, a 4.4% increase Company Reaffirms Full Year 2021 Guidance: Net Revenues of $107 million - $110 million, Adjusted EBITDA of $29 million - $30 million, and Operating Cash Flow of $21 million - $23 million. ROCHESTER HILLS, Michigan, March 17, 2021 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE:INFU), ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the fourth quarter and full year ended December 31, 2020. Fourth Quarter Highlights: